chrisvoncsefalvay/vaers-outcomes huggingface dataset:
STROKE, CVA, blood clot in brain;carotid artery-- medication, blood thinners and rehab--left side weakness, neglect; left paralyzed on left side- leg and arm and handL in-patient rehab for 5  weeks; hospitalized 2 weeks before that; consistent therapy to regain ability continues to date-- I have an ongoin bill at hospital that to date, is more than $1000.  I dont know how I'll ever pay that.
Immediately when I received the injection, I felt a cool fluid rush around my heart with a moderate discomfort/pain. I reported this to the tech who administered. He didn't seem alarmed & advised I wait 15 mins. I still felt a "coolness" around my chest but otherwise felt "fine" so I was permitted to leave. As the day went on, I felt my chest (lungs & area around my heart) feel tighter & tighter & my breath grew more & more "shallow" like I couldn't take deep enough breaths & I was short of breath. In the evening, it intensified. I was very fatigued (couldn't go up our stairs or talk in complete sentences without feeling "winded"). The tightness in my chest was worse & was accompanied by periodic acute pain in my heart. I also had pain my lower back. I went to the emergency room around 10PM that night. An EKG, blood tests & chest X-ray were conducted. The ER doctor said all tests came back "normal" & they weren't sure what my issue was. I went home & rested. I woke the next morning with the acute pains gone but the tightness still lingered. I did not feel "normal" until almost 72 hours after my vaccine.
booster; had Covid; had Covid; This is a spontaneous report received from contactable reporter(s) (Other HCP) for a Pfizer sponsored program.  A 60 year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: XELJANZ XR. The following information was reported: IMMUNISATION (medically significant), outcome "unknown", described as "booster"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "had Covid". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal relationship between the event Immunisation, Drug ineffective, covid-19 and suspect drug BNT162B2 cannot be excluded.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021 at 10:48 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 53.63  Concomitant medication information was not provided by the reporter.  Batch number 031A21A underwent temperature excursion on 20-Mar-2021 with temperature 34 degrees Fahrenheit from 09:00 AM. This vial was moved to fridge on 09-Mar-2021 and beyond use date for the vial was reported as 09-Apr-2021. Product moved to clinic on 20-Mar-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a temperature monitor at every hour.  Treatment information was not provided by the reporter.   This case was linked to MOD-2022-566976 (Patient Link).
This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE3592) via an unspecified route of administration in the left arm on 09Sep2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included bad disk in back. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN) for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3181) via an unspecified route of administration in the left arm on 16Aug2021 at 10:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 10Sep2021 at 07:00, the patient had swelling in left armpit. The patient woke up with a migraine and vomiting. On 11Sep2021, whole next day, the patient felt exhausted and slept. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling in left armpit, migraine, vomiting, exhausted and slept the whole next day were resolving at the time of this report.
THE HD WAS DOING A POP UP VACCINE CLINIC AT CHURCH. DURING THIS CLINIC, THIS PT WAITED FOR HER 15 MINUTES POST VACCINATION. WHEN HER TIME WAS UP SHE GOT UP AND CAME TO ME AND SAID "I DON'T FEEL RIGHT. I FEEL STRANGE" I SAT HER DOWN BESIDE ME AND STARTED QUESTIONING WHAT WAS GOING ON. SHE STATED THAT SHE HAS A SEVERE SHARP ABDOMINAL PAIN THAT FEELS LIKE SOMEONE IS STABBING HER WITH A KNIFE. SHE ALSO C/O NUMBNESS/TINGLING IN HER LEFT ARM, WHICH IS OPPOSITE THE SITE SHE WAS VACCINATED, AND THAT HER THUMB ON THE LEFT SIDE IS COMPLETELY NUMB. OFFERED PT WATER AND IMMEDIATELY BEGAN TAKING BP AND VITALS EVERY 5-10 MINUTES. FIRST BP READING AT 11:10 WAS 160/110. PT STATED THIS IS ABNORMALLY HIGH EVEN WITH HER HISTORY OF HTN. HR WAS 110. O2 95-98% WITH FINGER PULSE OX. PT ALSO STATED HER BP TENDS TO "RUN 20 OFF FROM OPPOSITE ARM AND ALL DOCTORS HAVE TO TAKE BOTH ARMS" SO WE BEGAN CHECKING BOTH ARMS WITH ALL BP CHECKS. PT WAS ALERT AND ORIENTED X 4, ACTIVE. SKIN WPD. RESP EVEN AND UNLABORED. CAP REFILL LESS THAN 3 SECONDS. WN, AND WD. AT 11:15 BP IN L ARM 130/90 AND R ARM 140/90. AT 11:23 O2 97% HR 92 BP R ARM 122/78, L ARM 120/80.  11:35 R ARM 126/88. 11:45 R ARM 124/90 AND L ARM 128/88. PT STATES THESE BP READINGS ARE MUCH MORE NORMAL FOR HER. PT STATED SHE FELT VERY FATIGUED AND TIRED BUT SHE BELIEVES THAT COULD BE HER ALLERGY MEDICINE. SHE WAS OFFERED AN AMBULANCE AND SHE DECLINED. SHE STATED SHE WOULD CALL HER PCP WHO IS DR.  WHEN SHE GETS HOME. PT STATED SHE WAS VERY NERVOUS ABOUT GETTING VACCINE AND THINKS MAYBE IT COULD BE NERVES. DENIES ANY PAST PROBLEMS WITH ANY OTHER VACCINES OR INJECTABLES JUST STATED THAT SHE TENDS TO BE VERY SENSITIVE TO SOME MEDICATIONS AND THERE ARE CERTAIN THINGS SHE CANT TAKE NOT BECAUSE OF AN ALLERGY, BUT BECAUSE SHE IS JUST SENSITIVE TO THOSE THINGS. PT WAITED AN ADDITIONAL 30 MINUTES AFTER HER INITIAL 15 MINUTE WAIT TIME AND BECUASE SHE WAS FEELING MUCH BETTER, AND STATED HER ABDOMINAL PAIN HAD SUBSIDED AS HAD THE NUMBNESS AND TINGLING IN HER ARM SHE WAS FINE TO GO HOME. SHE LIVES JUST ACROSS THE STREET AND HER HUSBAND IS CURRENTLY AT HOME WHO SHE IS TAKING TO THE DOCTOR IN JUST A COUPLE OF HOURS. REMINDED PT TO CALL HER OWN DOCTOR WHEN SHE GOT HOME AND TOLD HER I WOULD CALL HER THE NEXT DAY TO CHECK UP ON HER. TC TO HER ON 4/14/21 @1000. PT STATES SHE IS FEELING MUCH BETTER THAN YESTERDAY AND THAT SHE IS FINE TODAY.
Received 3rd dose of Gardasil on 3/31/09 On 4/2/09 she had an episode where she became very angry and agitated and had behavior not like her normal behavior. Mom said better after that day but concerned behavior related to vaccine
5pm 03/18/21 Heart palpitation, pulse rate 180, checked fitness watch ECG, showed SVT, Valsalva maneuver, converted to A-FIB/Flutter. 5:30pm ER visit and admission to ICU for Cardioversion. Preload of Amiodarone converted back to Normal Sinus Rhythm prior to cardioversion procedure. Home 03/20/21 Follow-up in 2 weeks with cardiologist.
pt recvd vax;exp paralysis side of face, ptosis, severe eczema & sweating; to 25 MD per mom;
The pt presented a prolonged crying for about 4 hrs, temperature of 103 deg F., slight redness at the injection site on the right leg. The pt was given Tylenol. She was diagnosed with a slight reaction to Prevnar.
Recieved vaccine and sat to be observed.  Noted flush from chest up to head of heat and then racing heart as well as increased blood pressure.  First set of vitals @ 0445 pm 97.7, bp 167/89, hr 74, r 20 . Pulse felt fast but was normal per assessment.  Second set of vitals @ 0458.  97.7, p68, BP 141/93, hr 92, O2 97.  Pulse higher. Md saw him and stated was ok to discharge with follow up with primary care MD.  Discharged at 5:10 pm.
Patient reported localized swelling, pain, rash and itching near the zostavax administration site, tingling in arm, generalized fever and overall pain in the arm starting the next day after administration. Administration was wednesday, symptoms began thursday. Pt came to pharmacy saturday evening, mentioning she is feeling better but still has all symptoms mentioned above. She used ibuprofen for the pain and fever, and benadryl for the rash and itching.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), in left arm and as dose 2, single (Batch/Lot number: unknown) at the age of 47 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Tested daily and went from positive to Negative; Negative, notes: Was negative for three days; Negative, notes: Was negative for three days; Negative, notes: Was negative for three days; Positive, notes: started to feel symptoms again and Tested positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Vaccine received. No other medication in 2 weeks. Anti viral details: product=COVID 19 Treatment, Brand=Paxlovid, Treatment start date=05Sep2022, Treatment stop date=10Sep2022, Indication=Treatment of COVID-19. Rebound Covid after taking Paxlovid. Patient tested daily and went from positive to Negative. Was negative for three days. Then started to feel symptoms again and tested positive. No known allergies. No medical history.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a consumer concerning a relative of hers, a 12 year old male patient. The patient's pertinent medical history and concurrent conditions were not provided. On an unspecified year, described as probably sometime between 2002 and 2006, the patient was vaccinated with a dose of M-M-R II (dose, route and lot# not provided). On an unknown date the patient experienced a mild case of autism and had autism symptoms described as hand slapping and other typical autism behaviors since he acted differently. The consumer reported that she was certain it was from the M-M-R II. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. This is one of several reports received from the same source. Additional information is not expected because there are no contact details.
Sitting in office, ear starting itch and feel funny changed my my throat started to swell which changed my voice.
Patient with DM, HTN and history of renal transplant with recent diagnosis of COVID who presents  complaining of abdominal discomfort, nausea, vomiting and shortness of breath found to be hypoxic to mid to high 80s by paramedics.    Nausea with nonbloody emesis x2, and generalized abdominal pain aching in nature and worse throughout upper abdomen.  Took his own zofran at home about 30 minutes prior to arrival.  Patient tested positive for COVID on 8/14/21, also with multiple risk factors including DM, HTN, and transplant patient
Dog bite; This spontaneous case was reported by an other health care professional and describes the occurrence of ANIMAL BITE (Dog bite) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for an unknown indication.    Previously administered products included for Dog bite: RABIES VACCINE. Past adverse reactions to the above products included No adverse event with RABIES VACCINE.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient started PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) (unknown route) Dose 1. In April 2021, the patient experienced ANIMAL BITE (Dog bite). At the time of the report, ANIMAL BITE (Dog bite) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Reporter did not allow further contact
Arm soreness started about 8 hours after injection.  By following morning, discomfort spread to shoulder, upper L chest/breast area  progressing into L axilla with swelling by the afternoon.  Fatigue and low grade fever (99.5-100) started early afternoon and lasted for approximately 36 hr.  Discomfort in axilla continued for most of a week with swelling slowly dissipating over next several weeks.  At 8 weeks as of today and L axilla not completely normal but much improved in last 2 weeks and not uncomfortable
This spontaneous report was received from a female consumer of an unknown age reporting on herself. There was no information about the patient's pertinent medical history, concurrent conditions, concomitant therapies, and drug reactions or allergies. On an unknown date reported as "years ago", the patient was vaccinated with a dose of ZOSTAVAX (strength, anatomical location, dose, frequency, route of administration, lot number, and expiration date were not provided) for prophylaxis. But, on an unspecified date, the patient experienced an outbreak of shingles (Herpes zoster) which was characterized by one large lesion in one of her breast. Additionally, the patient mentioned that also on an unknown date, she experienced oral thrush and tendinitis in one of her ears. It was reported that the patient sought unspecified medical attention. At the time of reporting it was unknown whether the patient recovered or not from the adverse events. The causal relationship between the therapy with ZOSTAVAX and the adverse events were not reported. No product quality complaint was involved. Additional information is not expected as there was no consent and information to contact the physician.
2 month vaccines were administered on July 27, 2011 and wrongfully administered on 8/12/2011.
GAVE PATIENT INCORRECT IMMUNIZATION. PATIENT WAS GIVEN TETANUS INSTEAD OF TYPHOID IN ERROR.
This spontaneous report as received from a medical assistant refers to a female patient of unknown age. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported. On 12-JUN-2018, the patient was vaccinated with a first dose of GARDASIL 9 injection, lot number: N028092, expiration date: 28-MAY-2020. On 28-AUG-2018, she was vaccinated with a second dose of GARDASIL 9 injection, lot number: R011628, expiration date: 11-DEC-2020. On 08-NOV-2018, she was vaccinated with a third dose of GARDASIL 9 injection, lot number: R017133, expiration date: 29-APR-2021. All the doses were administered intramuscularly (dose was not reported) for prophylaxis. No adverse effect was reported.
The patient stated she began having tingling and numbness in her left arm that began two to three days after she received her covid shot. The tingling gradually moved down her body into her legs.  She stated she no longer has tingling numbness in her arms or hands, but she occasionally will fill heat and tingling in her left leg.  She went to local Hospital, but the patient did not remember the name of the nurse practitioner that she saw.  The patient stated that the nurse told her her symptoms could be related to her poor circulation. The patient stated the nurse has scheduled her an appointment for some tests for her heart.
While waiting the 15 min after the shot, a warm sensation was going through my arm and down my left side to the center of my chest.  I could not breathe too well, I thought it was my mask causing this breathing issue; I did not tell the person who gave me the shot.  My 15 min was up so I went outside and took off the mask, I started feeling better.  I went home and my chest felt like someone was sitting on it.  I had shortness of breathe so I took two Excedrin migraine and then I started to feel better.  I worked the next day Friday April 16, I was not feeling up to par; my upper back between the shoulders were aching all day; never had this type of aching before.  I called my family Doctor, the nurse said not do anything all weekend but rest and if needed take Tylenol .  I rested all weekend and Sunday I went to the grocery store.  Monday April 19, I was so tired I called off work; Slept most of the day.  I have not been feeling well since.  Wednesday I had flu like symptoms; cold chills, sweating, aching muscles;  woke up twice wet from sweat, temp was 98.0.  Today Saturday April 24,  my back is starting to hurt again between the shoulders and I feel sluggish; I feel very tired.
Pt. states that after receiving the 1st dose of Phizer 03/10/2021, started experiencing symptoms 03/10/2021 of Numbness/tingling in the side of the head 3 weeks, PCP visit advised to get the 2nd shot,  Neurologist visit Cat Scan preformed states that maybe have symptoms of nerve damage.
The day after receiving  2nd dose, I experienced fatigue, body aches, headache and chills which lasted for about three days. The fatigue never cleared up, it only got worst. By day 4 I could not walk, climb stairs or stand for period of time without getting winded and extremely fatigued. This feeling still persist 8 days after being vaccinated.
numbness in my lower legs; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness in my lower legs) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness in my lower legs). At the time of the report, HYPOAESTHESIA (numbness in my lower legs) outcome was unknown.            concomitant and treatment drugs were not provided. Treatment information was not provided.
Sudden Cardiac arrest.  Pt had complained of indigestion previously during the day to his sons.  Pt was found by his sons pulseless, apneic and unresponsive  sitting in a couch.  They initiated CPR and called 911.  Fire department arrived and applied AED and delivered one shock.  Paramedic treated with Epinephrine and advanced airway.  Pt remained in asystole and after MD consultation pt was declared dead and CPR was stopped.  Pt had no recent illness.   Pt had done yard work earlier in the day without any complaints.  Pt's family states pt had his second dose of MRNA  Covid vaccine a month ago.
mom noted face got red, swelling around eyes & mouth w/in 10min of vax;given DPH;
Pt. called the day after PNEUMOVAX given with c/o fever body aches, chills, red swollen injection site - Pt. was subsequently seen 2 days later for pt. was not better. Injection site reaction 8.5 cm x 11 cm. Pt. treated with Cephalaxin and MEDROL dosepak. As of 11/18/13 pt. is better.
Severe violent shivering, freezing cold, which started the evening of getting the injection. Vomiting started during the night and all of the next day. The following day, today, headache, fatigue, and queasy stomach.
Severe sneezing, runny nose/post nasal drip, and coughing. Slight swelling of lips, tingly throat, swollen and red/irritated and itchy eyes. High Heart Rate, etc..
Information has been received from a RN concerning a 37 year old male with hayfever who on 21Apr04 at 3PM was vaccinated IM with a first 0.5ml dose of hep B virus vaccine rHBsAg (yeast) (lot 645420/0048N). There was no illness at the time of vaccination. Concomitant therapy that day at 3PM included a first dose typhoid vaccine (unspecified) PO to take home (batch #3000243). Additional concomitant medication included loratadine (Claritin) for hayfever and mometasone furoate (Nasonex). On 22Apr04 the pt developed heart palpitations. On 26Apr04 he developed a burning sensation traveling down his right leg. Unspecified medical attention was sought and no treatment was required. No product quality compliant was involved. Follow up information indicated that on 22Apr04 the pt felt hot flashes down his right leg from the knee down to the foot that was intermittent. He also had heart palpitations on that date. He was seen by his primary physician, who attributed the symptoms to cycling. It was noted to be mostly musculoskeletal in origin. The outcome was reported as recovered. No additional information is expected.
Fever set in around 24 hours after the shot. The fever's duration was about 2-4 hours. Most of the symptoms were body aches and lack of energy was constant a few hours after shot for the next two days.